| 參考文獻(xiàn) | [1]. Mingeot-Leclercq, M.P., et al., Piracetam inhibits the lipid-destabilising effect of the amyloid peptide Abeta C-terminal fragment. Biochim Biophys Acta, 2003. 1609(1): p. 28-38. [2]. Muller, W.E., et al., Effects of piracetam on membrane fluidity in the aged mouse, rat, and human brain. Biochem Pharmacol, 1997. 53(2): p. 135-40. [3]. Scheuer, K., et al., Piracetam improves cognitive performance by restoring neurochemical deficits of the aged rat brain. Pharmacopsychiatry, 1999. 32 Suppl 1: p. 10-6. |
|---|
相關(guān)活性
小分子 | (+)-MK 801 馬來(lái)酸鹽(馬來(lái)酸地佐環(huán)平)(mM/ml) | 6-氰基-7-硝基喹喔啉-2,3-二酮 | N-甲基-D-天冬氨酸水合物 | 酒石酸艾芬地爾 | (R)-(-)-2-氨基-5-膦酰戊酸 | 6,7-二硝基奎喔林-2,3(1H,4H)-二酮 | Ro 25-6981馬來(lái)酸鹽 | 馬來(lái)酸氟吡汀 | Mibampator | 苯并二氧六環(huán)-6-(1-哌啶基)甲酰胺 | Naspm | (8R)-7-乙?；?5-(4-氨基苯基)-8,9-二氫-8-甲基-7H-1,3-二氧雜環(huán)戊烯并[4,5-H][2,3]苯并二氮雜卓 | 鹽酸甲氯芬酯 | 24羥基膽固醇 |
|---|